Pulmonary Hypertension Trial, Recruiting NCT07535398 Sponsor: Marmara University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07535398
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old
  • People who have been found to have high blood pressure in the arteries of their lungs, measured at 50 mmHg or above on a heart ultrasound (echocardiography)
  • People whose condition is currently stable and who are being treated and monitored by a heart specialist, with mild or no limitations on physical activity (WHO functional class I or II)
  • People with mild or no limitations on their physical activity as rated by their doctor using the NYHA scale (class I or II)
  • People who live with a caregiver, family member, or someone else who can help them if needed
  • People who have internet access and are able to see, think clearly, and use technology well enough to take part in video call sessions
  • People who are willing to take part and able to give their informed consent to join the trial

Who may not be able to join:

  • People who need to use oxygen therapy
  • People who have bone, joint, or muscle problems that would prevent them from taking part in exercise
  • People who are currently receiving treatment for a psychiatric or psychological condition
  • People who have been found to have significant memory or thinking difficulties based on a standard cognitive test
  • People who have severe chronic obstructive pulmonary disease (a serious long-term lung condition) (confirm with trial site)
  • People who have another significant heart condition that could affect their participation or the results of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aysel Yıldız Özer, PhD, Marmara University

Phone: 00903562521616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Exercise Capacity; Dyspnea severity measured by the Modified Borg Dyspnea Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov